<span class="vcard">John Joseph</span>
John Joseph

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)

Dermatol Ther (Heidelb). 2024 May 2. doi: 10.1007/s13555-024-01157-5. Online ahead of print. ABSTRACT INTRODUCTION: Atopic dermatitis (AD) is characterized by intense itch and other symptoms …

Making a Bad Situation Worse: Current and Potential Unintended Consequences of Juvenile Registration for Sexual Offences

Arch Sex Behav. 2024 May 2. doi: 10.1007/s10508-024-02860-2. Online ahead of print. ABSTRACT Within the US, children and adolescents who engage in sexually abusive behavior …

Quantifying cigarette and e-cigarette marketing exposure among Chinese adolescents using ecological momentary assessment

Nicotine Tob Res. 2024 May 2:ntae103. doi: 10.1093/ntr/ntae103. Online ahead of print. ABSTRACT INTRODUCTION: Addressing cigarette and e-cigarette use in China is key to reducing …

IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey

J Med Internet Res. 2024 May 2;26:e49910. doi: 10.2196/49910. ABSTRACT BACKGROUND: To overcome knowledge gaps and optimize long-term follow-up (LTFU) care for childhood cancer survivors, …